Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6121613 | 0.98 | SMN1; SMN2 (0.49) | RXFP1GAAL3MBTL1CYP1A2CYP2C9 | |
| Hydrochlorthiazide SCHEMBL15796732 | 0.81 | ALDH1A1 (0.41) | RXFP1GAAL3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL286332 | 0.81 | ALDH1A1 (0.63) | GAAL3MBTL1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL423145 | 0.79 | RAB9A (0.47) | GAAL3MBTL1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL10672138 | 0.79 | ALDH1A1 (0.49) | RXFP1GAAL3MBTL1CYP1A2CYP2C9 | |
| Hydrochloric Acid SCHEMBL9528992 | 0.79 | ALDH1A1 (0.61) | GAAL3MBTL1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL3344131 | 0.79 | CNR1 (0.47) | GAAL3MBTL1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL1477812 | 0.79 | RAB9A (0.47) | GAAL3MBTL1CYP1A2ALDH1A1RAB9A | |
| SCHEMBL13165457 | 0.79 | RXFP1 (0.49) | RXFP1GAAL3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL289401 | 0.79 | RXFP1 (0.49) | RXFP1GAAL3MBTL1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118166368-A | Method for electrochemically synthesizing 2, 4-dimethyl-5-acetylthiazole | 江西师范大学 | 2024-06-11 | — | — | CN | claimed |
| US-20220370615-A1 | Prevention of Illicit Manufacture of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients | Satara Pharmaceuticals (US) | 2022-11-24 | — | — | US | claimed |
| CN-114790548-A | Palladium removing liquid for printed circuit board, palladium removing method and preparation method of printed circuit board | 深圳市板明科技股份有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-108618097-B | Salted egg yolk essence | 广州华宝食品有限公司 | 2021-07-27 | — | — | CN | claimed |
| EP-3809876-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2021-04-28 | — | — | EP | claimed |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | HENKEL AG & CO. KGAA (DE) | 2021-02-16 | — | — | US | claimed |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | PROCTER & GAMBLE (US) | 2020-05-14 | — | — | US | claimed |
| US-10568825-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-02-25 | — | — | US | claimed |
| WO-2019243869-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2019-12-26 | — | — | WO | claimed |
| CN-108936547-A | A kind of \"Zongzi\" flavour and preparation method thereof | 河南创新研霖食品科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0673784-B1 | Recording sheets containing oxazole, isooxazole, oxazolidinone, oxazoline salts, morpholine, thiazole, thiazolidine, thiadiazole, and phenothiazine compounds | XEROX CORP (US) | 1999-10-27 | — | — | EP | claimed |
| US-5665504-A | Simulated photographic-quality prints using a plasticizer to reduce curl | XEROX CORPORATION (US) | 1997-09-09 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673784-A2 | Recording sheets containing oxazole, isooxazole, oxazolidinone, oxazoline salts, morpholine, thiazole, thiazolidine, thiadiazole, and phenothiazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-RE29843-E | Substituted thiazoles and flavoring processes and products produced thereby | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-11-21 | — | — | US | claimed |
| US-4093752-A | FOODSTUFFS, CHEWING GUM, TOOTHPASTE, MEDICINES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-06-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568825-B2 | Antiperspirant and deodorant compositions | DEK, QDPR, GPX4 | RXFP1 4826/4885GAA 3418/4885L3MBTL1 3421/4885 |
| US-20220370615-A1 | Prevention of Illicit Manufacture of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients | MCHR1, TAAR5, COMT | RXFP1 3171/4885GAA 989/4885L3MBTL1 3069/4885 |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | NEFM, TRPA1, ALOX5 | RXFP1 2762/4885GAA 3613/4885L3MBTL1 2305/4885 |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | RXFP1 4826/4885GAA 3418/4885L3MBTL1 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.